OLV on the HILL: Women in Innovation

OLV Exec. Dir Robin Rasor testifying before Senate IP Subcommittee April 3rd, 2019

On April 3rd, Exec. Director Robin Rasor testified before the Senate Subcommittee on IP about the uniqueness of Duke’s model and how to encourage and retain women in STEM.

Read more
OLV on the HILL: Women in Innovation
On April 3rd, Exec. Director Robin Rasor testified before the Senate Subcommittee on IP about the uniqueness of Duke’s model and how to encourage and retain women in STEM.

INTERNATIONAL WOMAN'S DAY

Women in Innovation

This Women's Day, we highlighted just a few of the women at Duke making significant contributions to the world of science and innovation.

Learn More

AN INTERNATIONAL WOMEN'S DAY
Duke is an innovative place to be right now! We're highlighting just a few of the women here making significant contributions to the world of science and innovation.

Gavilan Checkmate

Using Supercomputers

to Checkmate Cancer

Gavilán Biodesign's ability to out-maneuver resistance, using AI technology to specially design drugs, has the potential to change the way drugs are made.

Learn More

Using Supercomputers to Checkmate Cancer
Gavilán Biodesign's ability to out-maneuver resistance, using AI technology to design drugs, has the potential to change the way drugs are made.

scientist hands with microscope, examining samples and liquid. Medical research with technical equipment

AskBio: 1st Patient in Phase

1/2 Study–Pompe Disease

Initial clinical study to evaluate ACTUS-101 over 52 weeks that could improve quality of life for those who are affected with rare genetic disorder - Pompe Disease.

Learn More

TECH TRANSFER NEWS

AskBio: 1st Patient Dosed in Phase 1/2 Study for Pompe Disease
Initial clinical study to evaluate ACTUS-101 over 52 weeks that could improve quality of life for those who are affected with rare genetic disorder - Pompe Disease.

START-UP

Our 2018 Annual Report has arrived!

Discover the incredible things the Duke Office of Licensing and Ventures is accomplishing.

Learn More

BY THE NUMBERS

Our 2018 Annual Report has arrived!
Discover the incredible things the Duke Office of Licensing and Ventures is accomplishing.

From Idea to Industry

The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University

Take the first step
Road map Created with Sketch. Revenue received from licensing is distributed to inventors, the inventors’ primary department, and Duke University for investment in future research . We market and license the technology to an existing business, or assist you in creating a new entity as a licensee (a “start-up”). We work with you to identify resources for you or third parties to continue development of your invention to de-risk it further for commercialization. In consultation with you, we determine the best method for protecting your invention, usually via patent or copyright protection. We assess your invention using criteria including patentability, stage of development, and marketability. Submit your invention using a Disclosure Form (see above for link) or contact us for a pre-disclosure meeting. Where it all begins: the raw material behind your potential ideas and inventions.

From Idea to Industry

The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University

Take the first step

From Idea to Industry

The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University

Take the first step
 

Faculty & Innovators

Start here

Industry & Investors

START HERE

Resources

START HERE